Page last updated: 2024-08-26

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and morphine

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with morphine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bespalov, A; Kudryashova, M; Zvartau, E1
Balster, RL; Beardsley, PM; Bespalov, AY1
Belozertseva, IV; Bespalov, AY; Danysz, W; Dravolina, OA; Neznanova, ON1
Bespalov, AY; Blokhina, EA; Sukhotina, IA1
Maeda, A; Minami, M; Nakagawa, T; Satoh, M; Watanabe, T; Yamamoto, R1

Other Studies

5 other study(ies) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and morphine

ArticleYear
Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats.
    European journal of pharmacology, 1998, Jun-26, Volume: 351, Issue:3

    Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Synergism; Escape Reaction; Excitatory Amino Acid Antagonists; Male; Morphine; Pain Measurement; Piperazines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Tail; Time Factors

1998
N-Methyl-D-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:1

    Topics: Animals; Discrimination Learning; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid Antagonists; Male; Morphine; Narcotics; Piperazines; Piperidines; Pyrrolidinones; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate

1999
Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval.
    European journal of pharmacology, 2000, May-19, Volume: 396, Issue:2-3

    Topics: Analgesics; Animals; Drug Synergism; Drug Therapy, Combination; Drug Tolerance; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Memantine; Mice; Morphine; Piperazines; Receptors, N-Methyl-D-Aspartate

2000
Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: effects of NMDA receptor antagonists.
    European journal of pharmacology, 2000, Oct-13, Volume: 406, Issue:2

    Topics: Animals; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Antagonists; Male; Memantine; Mice; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Piperazines; Receptors, N-Methyl-D-Aspartate

2000
Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
    Japanese journal of pharmacology, 2002, Volume: 88, Issue:4

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amygdala; Analysis of Variance; Animals; Avoidance Learning; Cerebellar Nuclei; Conditioning, Psychological; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Male; Microinjections; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Substance Withdrawal Syndrome

2002